NCT02365246View on ClinicalTrials.gov

Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD)

PHASE2RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Atopic Dermatitis
Interventions
DEVICE

immunoadsorptions with an IgE-specific adsorption column

immunoadsorptions

Trial Locations (1)

3000

RECRUITING

UZ Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT02365246 - Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD) | Biotech Hunter | Biotech Hunter